Czuczman, M S <br/><br/>
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1999 
 - 268-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1999.17.1.268  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Immunoglobulins--analysis<br/>Lymphoma, B-Cell--genetics<br/>Lymphoma, Non-Hodgkin--genetics<br/>Male<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Prednisone--administration & dosage<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Rituximab<br/>Translocation, Genetic<br/>Vincristine--administration & dosage